Basic Information
ID: ALA4606546
Type: Functional
Description: Protection against reactivation of type 2 Toxoplasma gondii ME49 infection in sulfadiazin-treated Ifngr1-/- CD1 mouse assessed as reduction in serological conversion at 60 mg/kg, po administered twice daily via gavage for 21 days followed by brain isolation on 30 days post-infection and co-culture with Ifngr1-/- CD1 mouse
Organism: Toxoplasma gondii
Strain: ME49
Activity Charts
Bioactivity
Activity Types for Assay ALA4606546
Activity
Compound Summary
| Parent Molecular Weight | ALogP | Polar Surface Area |
|---|---|---|
| 336.28 | 2.95 | 2.95 |